Alexandria Real Estate Equities (ARE)
NYSEReal EstateReit - OfficeSnapshot 2026-09-04
$52.65-0.08%
Close 2026-09-04 · 1-day change
NYSEReal EstateReit - OfficeSnapshot 2026-09-04
QuarterlyIQ Insights · ARE
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 3 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $53 ARE trades at 37× p/ffo — 2.8× the 13× p/ffo peer median. The market is re-rating it beyond its own range; our $47 fair value is low-confidence here. Analysts target $52–$60. Note: our $47 fair value sits below the entire analyst range ($52–$60). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
The price sits about 11% above a flat-multiple fair value, while analysts forecast about -35% growth — well above our forecast. This describes what's priced in, not a forecast of the move.
TTM earnings are negative, so the read leans on sales- and cash-flow-based methods rather than P/E. This is a data condition, not a forward call.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $53.50 | — | — | Analyst | high |
| Peer P/FFO | 12M | $18.62 | 13.2 | 1.41 | TTM | high |
| Peer P/S | 12M | $63.71 | 3.8 | 16.64 | TTM | high |
| Peer P/S | 3Y | $17.87 | 3.8 | 4.67 | Analyst | medium |
| Peer P/S | 5Y |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
$52.00 – $60.00 (median $53.50) · 8 analysts · as of 2026-08-24
Looks cheaper than most peers in the same business.
Self-history needs ~20 months of data.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $7.66 |
| 3.8 |
| 2.00 |
| Analyst |
| medium |